Literature DB >> 17324960

Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii.

Jordi Vila1, Sara Martí, Javier Sánchez-Céspedes.   

Abstract

Acinetobacter baumannii is an opportunistic pathogen, causing infections mainly in patients in intensive care units where the extensive use of antimicrobial agents can select for the emergence of multiresistant strains. In fact, since strains resistant to all antimicrobial agents have been reported, A. baumannii is considered the paradigm of multiresistant bacteria. Both acquired and intrinsic resistance can contribute to multiresistance. The ability to acquire multidrug resistance can be due to either the acquisition of genetic elements carrying multiple resistant determinants or mutations affecting the expression of porins and/or efflux pump(s), which can affect unrelated antimicrobial agents. Meanwhile, intrinsic resistance can be generated by the interplay of decreased permeability and constitutive expression of active efflux systems and it too can affect unrelated antimicrobial agents. This review is focused on the current knowledge of porins and efflux pump(s) in this microorganism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17324960     DOI: 10.1093/jac/dkl509

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  135 in total

1.  Genomics-driven reconstruction of acinetobacter NAD metabolism: insights for antibacterial target selection.

Authors:  Leonardo Sorci; Ian Blaby; Jessica De Ingeniis; Svetlana Gerdes; Nadia Raffaelli; Valérie de Crécy Lagard; Andrei Osterman
Journal:  J Biol Chem       Date:  2010-10-06       Impact factor: 5.157

2.  Genomic comparison of multi-drug resistant invasive and colonizing Acinetobacter baumannii isolated from diverse human body sites reveals genomic plasticity.

Authors:  Jason W Sahl; J Kristie Johnson; Anthony D Harris; Adam M Phillippy; William W Hsiao; Kerri A Thom; David A Rasko
Journal:  BMC Genomics       Date:  2011-06-04       Impact factor: 3.969

3.  Deletion of TnAbaR23 results in both expected and unexpected antibiogram changes in a multidrug-resistant Acinetobacter baumannii strain.

Authors:  Mandira Kochar; Marialuisa Crosatti; Ewan M Harrison; Barbara Rieck; Jacqueline Chan; Chrystala Constantinidou; Mark Pallen; Hong-Yu Ou; Kumar Rajakumar
Journal:  Antimicrob Agents Chemother       Date:  2012-01-30       Impact factor: 5.191

Review 4.  Therapies for multidrug resistant and extensively drug-resistant non-fermenting gram-negative bacteria causing nosocomial infections: a perilous journey toward 'molecularly targeted' therapy.

Authors:  Nadim G El Chakhtoura; Elie Saade; Alina Iovleva; Mohamad Yasmin; Brigid Wilson; Federico Perez; Robert A Bonomo
Journal:  Expert Rev Anti Infect Ther       Date:  2018-01-16       Impact factor: 5.091

5.  Identification of a Novel Plasmid Carrying mcr-4.3 in an Acinetobacter baumannii Strain in China.

Authors:  Furong Ma; Cong Shen; Yong Xia; Guo-Bao Tian; Xiaobin Zheng; Yan Liu; Hongtao Chen; Lanlan Zhong; Yingjian Liang; Kang Liao; Yongqiang Yang
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

6.  Vaccination with outer membrane complexes elicits rapid protective immunity to multidrug-resistant Acinetobacter baumannii.

Authors:  Michael J McConnell; Juan Domínguez-Herrera; Younes Smani; Rafael López-Rojas; Fernando Docobo-Pérez; Jerónimo Pachón
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

7.  Two mechanisms of killing of Pseudomonas aeruginosa by tobramycin assessed at multiple inocula via mechanism-based modeling.

Authors:  Jürgen B Bulitta; Neang S Ly; Cornelia B Landersdorfer; Nicholin A Wanigaratne; Tony Velkov; Rajbharan Yadav; Antonio Oliver; Lisandra Martin; Beom Soo Shin; Alan Forrest; Brian T Tsuji
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191

8.  First detection of OXA-24 carbapenemase-producing Acinetobacter baumannii isolates in Bulgaria.

Authors:  Bozhana Todorova; Tzvetan Velinov; Ivan Ivanov; Elina Dobreva; Todor Kantardjiev
Journal:  World J Microbiol Biotechnol       Date:  2013-11-28       Impact factor: 3.312

9.  In Vitro Activity of the Ultra-Broad-Spectrum Beta-Lactamase Inhibitor QPX7728 in Combination with Meropenem against Clinical Isolates of Carbapenem-Resistant Acinetobacter baumannii.

Authors:  Kirk Nelson; Debora Rubio-Aparicio; Ruslan Tsivkovski; Dongxu Sun; Maxim Totrov; Michael Dudley; Olga Lomovskaya
Journal:  Antimicrob Agents Chemother       Date:  2020-10-20       Impact factor: 5.191

10.  Biscatecholate-monohydroxamate mixed ligand siderophore-carbacephalosporin conjugates are selective sideromycin antibiotics that target Acinetobacter baumannii.

Authors:  Timothy A Wencewicz; Marvin J Miller
Journal:  J Med Chem       Date:  2013-05-08       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.